SOL Global Founded Portfolio Company HeavenlyRx Announces The Appointment Of Top Rated Weekend News Host and NY Times Best-Selling Author Judge Jeanine Pirro To Its Board of Directors

FORT LAUDERDALE, FL, July 31, 2019 /CNW/ - HeavenlyRx Ltd. ("HeavenlyRx" or "Company"), a global hemp and CBD company founded by SOL Global, is pleased to announce the appointment of television personality and legal expert Judge Jeanine Pirro ("Judge Jeanine" or "Pirro") to its board of directors, effective immediately.

Judge Jeanine is the host of Fox News Channel's top-rated "Justice with Judge Jeanine" and a frequent guest on other primetime shows. Before becoming a television personality more than a decade ago, Pirro had a distinguished legal career, scoring two firsts for women. In 1991, she was the first woman to be elected to county court judge. Two years later, she became the first woman to be elected Westchester County District Attorney.

As a media personality and former public official versed in a wide variety of legal and political issues, Judge Jeanine brings decades of insight and perspective to bear on the emerging CBD and hemp marketplaces. Pirro is also the author of six books, including one New York Times Best Seller.  She is a graduate of the State University of New York at Buffalo and Albany Law School of Union University where she was an editor of the law review.

CBD is growing in the health and wellness sector, particularly among women who are the leading demographic for CBD products, making up 58% of all users of CBD according to the Brightfield Group. Judge Jeanine will be invaluable with her insights into CBD and it's potential markets.

"I am honoured to join the board of directors of HeavenlyRx," said Pirro. "As the emerging markets for CBD and hemp begin to explode in the United States, it is a privilege to hold a leadership position in a company that is ahead of the curve. I hope to use the lessons learned from years of experience in television to help amplify this brand, a frontrunner in the wellness space and increase shareholder value."

"Having someone as high profile and respected as Judge Jeanine Pirro is a huge win for our Company," said Paul Norman, CEO of HeavenlyRx and former President of North America for the food giant Kellogg. "Judge Pirro offers HeavenlyRx a wealth of insight and expertise in media strategies, law, and consumer preferences that we hope will expand our footprint in the emerging hemp and CBD markets."

About Heavenly Rx Ltd.

HeavenlyRx is the CBD and Hemp focused portfolio company of SOL Global Investments. Heavenly Rx holds controlling ownership interests in various industry-leading assets in the hemp/CBD and THC-free cannabinoid wellness space, with a focus on hemp cultivation, processing and the manufacturing of a diverse range of traditional CBD products including oils, tinctures, balms, and vape-ready products. Heavenly Rx's portfolio will include several proprietary brands across numerous consumer product group verticals, including cosmetics and beauty products, bath and body products, and infused foods with a focus on the CPG market. HeavenlyRx was founded by SOL Global Investments in early 2019

Cautionary Statements

This press release contains "forward-looking information" within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy. Some of the forward-looking information contained in this press release include, but are not limited to, statements with respect to: the Company’s potential market and the Company’s business opportunities.

By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, but are not limited to: the Company's ability to comply with all applicable governmental regulations in a highly regulated business; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US federal laws; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; inconsistent public opinion and perception regarding the medical-use and adult-use marijuana industry; and regulatory or political change.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

SOURCE HeavenlyRx Ltd.

HeavenlyRx Ltd., Rhonda Bevan, P: 954-319-9995, E: [email protected]; For media inquiries, please contact: Vito Palmeri, AMWPR, P: 212.542.3146, E: [email protected]